Gastrointestinal

The Pharmacy Times® Gastrointestinal resource center provides news and articles centered around the FDA approved drugs in gastroenterology, as well as links to condition-specific resources, and videos and other content.

What can we help you find?
[[thumbnail_alt_text]]
Despite presenting in only 18% of cases, 16% of all COVID-19 patients only present with gastrointestinal symptoms. 
 
[[thumbnail_alt_text]]
The FDA granted breakthrough therapy designation to dupilumab in September 2020, for the treatment of patients age 12 years and older with eosinophilic esophagitis.
[[thumbnail_alt_text]]
Educate patients about the appropriate and safe use of gastrointestinal products and direct them to seek further medical care when warranted.
[[thumbnail_alt_text]]
Like diabetes, Inflammatory bowel disease may also be linked to a high-fructose diet. 
[[thumbnail_alt_text]]
Pharmacists can play an integral role in collaborating with physicians to manage patient therapy.
[[thumbnail_alt_text]]
Nizatidine Oral Solution is a prescription oral product used for the short-term treatment and maintenance therapy of ulcers and for the treatment of esophagitis and associated heartburn due to GERD.
[[thumbnail_alt_text]]
Irritable bowel disease, such as ulcerative colitis and Crohn disease, can increase the risk of both cancer and death. 
 
[[thumbnail_alt_text]]
According to a study published in Genome Medicine, the disruption of gut bacteria through the use of antibiotics soon after birth has the ability to affect the immune system’s process of maturation.
[[thumbnail_alt_text]]
A variety of OTC products, such as antacids, histamine H2 receptor antagonists (H2RAs), and proton pump inhibitors (PPIs), are available to help manage symptoms of gastroesophageal reflux disease (GERD).
[[thumbnail_alt_text]]
Mylan plans to launch adalimumab-fkjp in the United States in July 2023.
[[thumbnail_alt_text]]
According to an online survey of more than 53,000 Americans using PPIs, once or twice daily use significantly increases the likelihood of a positive test for COVID-19.
[[thumbnail_alt_text]]
According to a recent study published in Gut, inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn disease, is associated with a more than doubled likelihood of developing dementia.